Trials / Not Yet Recruiting
Not Yet RecruitingNCT06494956
To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease
A Prospective, Single-center, Open Clinical Study to Evaluate the Safety of Implantable Rechargeable Computerized Deep Nerve Stimulation Systems in Patients With Primary Parkinson's Disease
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (estimated)
- Sponsor
- Jiangsu CED Medtech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety of implantable rechargeable computer deep nerve stimulation system produced by Jiangsu Changyida Medical Technology Co., Ltd. for patients with primary Parkinson's disease
Detailed description
To evaluate the safety of implantable rechargeable computer deep nerve stimulation system produced by Jiangsu Changyida Medical Technology Co., Ltd. for patients with primary Parkinson's disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Implant device | A subcutaneous tunnel was established under general anesthesia, the electrode was connected to the stimulator, and the pulse generator was implanted in the skull. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-10-31
- Completion
- 2025-07-31
- First posted
- 2024-07-10
- Last updated
- 2024-07-10
Source: ClinicalTrials.gov record NCT06494956. Inclusion in this directory is not an endorsement.